Ventilator-associated pneumonia: Difference between revisions
Jump to navigation
Jump to search
| Line 16: | Line 16: | ||
==Treatment== | ==Treatment== | ||
[[Ventilator-associated pneumonia clinical strategy|Recommendations for | [[Ventilator-associated pneumonia clinical strategy|Recommendations for Clinical Strategy]] | [[Ventilator-associated pneumonia medical therapy|Medical Therapy]] | [[Ventilator-associated pneumonia prevention|Prevention]] | [[Hospital-acquired pneumonia response to therapy|Assessing Response to Therapy]] | ||
==Related Chapters== | ==Related Chapters== | ||
* [[Pneumonia]] | * [[Pneumonia]] | ||
Revision as of 21:27, 29 January 2013
Template:Ventilator-associated pneumonia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Ventilator-Associated Pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray
Treatment
Recommendations for Clinical Strategy | Medical Therapy | Prevention | Assessing Response to Therapy